EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Chronic Exposure to Ah Receptor‐Responsive Tryptophan Metabolites Impacts Head and Neck Carcinoma Cell Phenotype

Dhwani Patel, Denise M Coslo, Iain A Murray, Ethan W Morgan, Hunter C Trithart, Dhimant Desai, Shantu G Amin, Andrew D Patterson iD, Gary H Perdew iD

The FASEB Journal · 30.11.2026 · 40 (22)

DOI: 10.1096/fj.202603044rr ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 15.11.2026. Verfasst von Dhwani Patel und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, The Pennsylvania State University, University Park, Pennsylvania, USA. Hauptthemen laut MEDLINE: Receptors, Aryl Hydrocarbon, Tryptophan, Head and Neck Neoplasms, Squamous Cell Carcinoma of Head and Neck. Die Arbeit nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, National Institute of Environmental Research (NIER), NIEHS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aryl hydrocarbon receptor (AHR) is a ligand‐activated transcription factor implicated in inflammation, immune modulation, and tumor progression. Head and neck squamous cell carcinoma (HNSCC) exhibits elevated AHR expression and basal AHR activity, suggesting that persistent receptor signaling may contribute to tumor behavior. While sustained activation by environmental AHR ligands has been linked to tumor‐promoting phenotypes, the effects of chronic exposure to physiologically relevant endogenous AHR agonists remain poorly defined. Circulating tryptophan (Tryp) metabolites, including kynurenine and indole derivatives, are continuously present in human serum and collectively contribute to basal AHR activity. Here, we examined whether prolonged exposure to a defined mixture of serum‐derived Tryp metabolites promotes aggressive tumor phenotypes in HNSCC. Using a custom dish‐in‐dish culture system to model sustained exposure, we observed persistent AHR activation in HNSCC cells, evidenced by induction of canonical target genes and nuclear AHR translocation. Transcriptomic profiling revealed upregulation of inflammatory and tumor‐associated programs, including CSF3, MMP1, and AP‐1–associated targets. Assay for Transposase‐Accessible Chromatin (ATAC)‐seq analysis demonstrated ligand‐dependent chromatin remodeling and enrichment of inflammatory transcription factor motifs, supporting epigenetic reprogramming during prolonged AHR activation. Sustained Tryp metabolite exposure also enhanced cytokine secretion, proliferation, clonogenic survival, migration, and invasive capacity, many of which were attenuated by pharmacologic AHR antagonism. Together, these findings demonstrate that chronic exposure to endogenous Tryp metabolites drives sustained tumor‐intrinsic AHR signaling and promotes aggressive phenotypes in HNSCC, identifying AHR as a potential contributor to tumor progression and a candidate therapeutic target in HNSCC tumors exhibiting elevated AHR activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Aryl HydrocarbonTryptophanHead and Neck NeoplasmsSquamous Cell Carcinoma of Head and NeckBasic Helix-Loop-Helix ProteinsHumansCell Line, TumorGene Expression Regulation, NeoplasticPhenotypeSignal TransductionCell ProliferationKynurenineCell Movement

Stichwörter der Autor:innen

AHRATAC seqRNA seqcancercell migrationindole derivativeskynureninetryptophan

Substanzen

Receptors, Aryl HydrocarbonTryptophanAHR protein, humanBasic Helix-Loop-Helix ProteinsKynurenine

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Biology, The Pennsylvania State University, University Park, Pennsylvania, USA.
  • Department of Veterinary and Biomedical Sciences, Center for Molecular Toxicology and Carcinogenesis, The Pennsylvania State University, University Park, Pennsylvania, USA.
  • Department of Molecular and Precision Medicine, Penn State College of Medicine, Hershey, Pennsylvania, USA.

ORCID-Profile: Andrew D Patterson, Gary H Perdew

Förderung

  • NIDDK NIH HHS
  • National Institute of Environmental Research (NIER)
  • NIEHS NIH HHS
  • HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  • HHS | NIH | National Institute of Environmental Health Sciences (DEHS)
  • National Institute of Environmental Health Sciences
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Patel, D., Coslo, D. M., Murray, I. A., Morgan, E. W., Trithart, H. C., Desai, D., Amin, S. G., Patterson, A. D., & Perdew, G. H. (2026). Chronic Exposure to Ah Receptor‐Responsive Tryptophan Metabolites Impacts Head and Neck Carcinoma Cell Phenotype. The FASEB Journal, 40(22). https://doi.org/10.1096/fj.202603044rr

Vancouver

Patel D, Coslo DM, Murray IA, Morgan EW, Trithart HC, Desai D, et al. Chronic Exposure to Ah Receptor‐Responsive Tryptophan Metabolites Impacts Head and Neck Carcinoma Cell Phenotype. The FASEB Journal. 2026;40(22). doi:10.1096/fj.202603044rr

BibTeX
@article{Patel2026,
  author = {Patel, Dhwani and Coslo, Denise M and Murray, Iain A and Morgan, Ethan W and Trithart, Hunter C and Desai, Dhimant and Amin, Shantu G and Patterson, Andrew D and Perdew, Gary H},
  title = {Chronic Exposure to Ah Receptor‐Responsive Tryptophan Metabolites Impacts Head and Neck Carcinoma Cell Phenotype},
  journal = {The FASEB Journal},
  year = {2026},
  volume = {40},
  number = {22},
  doi = {10.1096/fj.202603044rr}
}
Kostenlos starten →